AR021459A1 - PARCHE QUE CONTIENE ESTRADIOL PARA LA APLICACIoN PERCUTÁNEA DE HORMONAS. - Google Patents

PARCHE QUE CONTIENE ESTRADIOL PARA LA APLICACIoN PERCUTÁNEA DE HORMONAS.

Info

Publication number
AR021459A1
AR021459A1 ARP990103732A ARP990103732A AR021459A1 AR 021459 A1 AR021459 A1 AR 021459A1 AR P990103732 A ARP990103732 A AR P990103732A AR P990103732 A ARP990103732 A AR P990103732A AR 021459 A1 AR021459 A1 AR 021459A1
Authority
AR
Argentina
Prior art keywords
patch containing
hormones
active ingredient
percutaneous application
containing estradiol
Prior art date
Application number
ARP990103732A
Other languages
English (en)
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7875613&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR021459(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of AR021459A1 publication Critical patent/AR021459A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/65—Characterized by the composition of the particulate/core
    • A61K2800/651—The particulate/core comprising inorganic material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

Un parche que contiene sustancia activa para la emision controlada de estradiol o de sus derivados farmacéuticamente inofensivos, solos o en combinacioncon gestágenos, a la piel humana o animal, a partir de una capa posterior, un deposito unido a lamisma que contiene principio activo, adecuado para la emisioncombinada de principio activo, que se fabrica utilizando adhesivos de contacto, y una capa protectora separable, que se caracteriza por el hecho de que eladhesivo de contacto contienelanol ina o componentes de la misma y oxido de zinc.
ARP990103732A 1998-07-29 1999-07-28 PARCHE QUE CONTIENE ESTRADIOL PARA LA APLICACIoN PERCUTÁNEA DE HORMONAS. AR021459A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19834007A DE19834007C1 (de) 1998-07-29 1998-07-29 Estradiolhaltiges Pflaster zur transdermalen Applikation von Hormonen und seine Verwendung

Publications (1)

Publication Number Publication Date
AR021459A1 true AR021459A1 (es) 2002-07-24

Family

ID=7875613

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990103732A AR021459A1 (es) 1998-07-29 1999-07-28 PARCHE QUE CONTIENE ESTRADIOL PARA LA APLICACIoN PERCUTÁNEA DE HORMONAS.

Country Status (18)

Country Link
US (1) US6531149B1 (es)
EP (1) EP1100477B1 (es)
JP (1) JP2002521427A (es)
KR (1) KR100559089B1 (es)
CN (1) CN1172661C (es)
AR (1) AR021459A1 (es)
AT (1) ATE264097T1 (es)
AU (1) AU758107B2 (es)
BR (1) BR9912687A (es)
CA (1) CA2338859C (es)
DE (2) DE19834007C1 (es)
ES (1) ES2220093T3 (es)
IL (2) IL141033A0 (es)
PL (1) PL194102B1 (es)
TR (1) TR200100289T2 (es)
TW (1) TW542726B (es)
WO (1) WO2000006131A1 (es)
ZA (1) ZA200100719B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10304988A1 (de) * 2003-02-07 2004-09-09 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System mit verbessertem Hautklebeverhalten
WO2005000198A2 (en) 2003-05-07 2005-01-06 Cedars-Sinai Medical Center An intracellular estradiol binding protein, a polynucleotide encoding the same and cell lines overexpressing the same
US7251128B2 (en) * 2004-09-30 2007-07-31 Intel Corporation Adjustable portable computer
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
LT2782584T (lt) 2011-11-23 2021-09-10 Therapeuticsmd, Inc. Natūralios kombinuotos pakaitinės hormonų terapijos kompozicijos ir gydymas
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE251567C (es)
NL6902314A (es) 1969-02-13 1970-08-17
US3637224A (en) 1969-02-27 1972-01-25 Fedders Corp Annular sealing ring
US4379454A (en) 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
CA1248450A (en) * 1984-04-05 1989-01-10 Kazuo Kigasawa Soft patch
US4624665A (en) 1984-10-01 1986-11-25 Biotek, Inc. Method of transdermal drug delivery
US4720489A (en) * 1984-10-15 1988-01-19 Douglas Shander Hair growth modification with ornithine decarboxylase inhibitors
ATE95430T1 (de) * 1984-12-22 1993-10-15 Sanol Arznei Schwarz Gmbh Wirkstoffpflaster.
US4883669A (en) 1985-02-25 1989-11-28 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for estradiol and other estrogenic steroids and process for administration
DD251567A1 (de) * 1986-07-30 1987-11-18 Jenapharm Veb Verfahren zur herstellung gefaerbter, selbstklebender loesungsmittelhaltiger polymermischungen
CN1021196C (zh) 1986-12-29 1993-06-16 新泽西州州立大学(鲁杰斯) 透皮雌激素/孕激素药剂单元、系统及方法
CH674618A5 (es) 1987-04-02 1990-06-29 Ciba Geigy Ag
DE3743946A1 (de) 1987-09-01 1989-03-09 Lohmann Gmbh & Co Kg Vorrichtung zur abgabe von nitroglycerin an die haut, verfahren zu ihrer herstellung sowie ihre verwendung
US4906475A (en) 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
JPH02180835A (ja) * 1988-12-29 1990-07-13 Lion Corp 外用製剤
EP0409383B1 (en) * 1989-07-21 1994-04-06 Izhak Blank Estradiol compositions and methods for topical applications
AU644815B2 (en) * 1989-09-08 1993-12-23 Ortho-Mcneil Pharmaceutical, Inc. Solid matrix system for transdermal drug delivery
JP3273430B2 (ja) * 1989-12-28 2002-04-08 日東電工株式会社 エストロゲン含有ゲル製剤
DE4115849A1 (de) * 1991-05-15 1992-11-19 Lohmann Therapie Syst Lts Penetrationsfoerdernde substanz
JPH04342532A (ja) * 1991-05-21 1992-11-30 Sekisui Chem Co Ltd 経皮吸収貼付剤
JP3086288B2 (ja) * 1991-07-23 2000-09-11 扶桑薬品工業株式会社 経皮吸収製剤
JPH05148135A (ja) * 1991-11-29 1993-06-15 L T T Kenkyusho:Kk 貼付剤用物理的吸収促進剤及びそれを含む貼付剤
DE4230588C1 (de) * 1992-09-12 1993-10-07 Lohmann Therapie Syst Lts Dexpanthenol-haltiges Pflaster zur transdermalen Applikation von Steroidhormonen und Verfahren zu seiner Herstellung
JP2569396B2 (ja) * 1992-12-04 1997-01-08 株式会社太平洋 経皮投与型薬物用貼付剤
JP3197102B2 (ja) * 1993-03-29 2001-08-13 積水化学工業株式会社 経皮吸収製剤及びその製造方法
JP3305101B2 (ja) * 1994-03-29 2002-07-22 積水化学工業株式会社 経皮吸収製剤
DE4416927C1 (de) * 1994-05-13 1995-08-31 Lohmann Therapie Syst Lts Vorrichtung zur Abgabe von Wirkstoffen aus Haftschmelzklebern, Verfahren zu ihrer Herstellung und ihre Verwendung
JPH0827003A (ja) * 1994-07-22 1996-01-30 Sekisui Chem Co Ltd 経皮吸収製剤
WO1996015776A1 (fr) * 1994-11-18 1996-05-30 Hisamitsu Pharmaceutical Co., Inc. Timbre absorbable par voie percutanee
EP0746311B1 (en) * 1994-12-24 2001-07-11 Pacific Corporation Medicinal patches for percutaneous administration
UA48973C2 (uk) * 1995-06-07 2002-09-16 Орто-Макнейл Фармасьютікалз Інк. Трансдермальний пластир на основі 17-деацетилноргестимату для попередження овуляції
US5783208A (en) * 1996-07-19 1998-07-21 Theratech, Inc. Transdermal drug delivery matrix for coadministering estradiol and another steroid
US5948433A (en) * 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch

Also Published As

Publication number Publication date
ES2220093T3 (es) 2004-12-01
CA2338859A1 (en) 2000-02-10
CN1172661C (zh) 2004-10-27
AU5160799A (en) 2000-02-21
ZA200100719B (en) 2002-06-14
ATE264097T1 (de) 2004-04-15
EP1100477B1 (de) 2004-04-14
CA2338859C (en) 2007-09-18
KR100559089B1 (ko) 2006-03-13
TW542726B (en) 2003-07-21
PL194102B1 (pl) 2007-04-30
WO2000006131A1 (de) 2000-02-10
EP1100477A1 (de) 2001-05-23
TR200100289T2 (tr) 2001-07-23
DE19834007C1 (de) 2000-02-24
JP2002521427A (ja) 2002-07-16
PL345695A1 (en) 2002-01-02
KR20010079571A (ko) 2001-08-22
BR9912687A (pt) 2001-06-05
CN1310614A (zh) 2001-08-29
DE59909189D1 (de) 2004-05-19
US6531149B1 (en) 2003-03-11
IL141033A (en) 2009-06-15
AU758107B2 (en) 2003-03-13
IL141033A0 (en) 2002-02-10

Similar Documents

Publication Publication Date Title
AR021459A1 (es) PARCHE QUE CONTIENE ESTRADIOL PARA LA APLICACIoN PERCUTÁNEA DE HORMONAS.
AR042815A1 (es) Dispositivo de suministro de agente activo que tiene miembros compuestos
BR9815378A (pt) Sistema de fornecimento de droga transdérmico para agente analgésico antiinflamatório compreendendo sal de dietilamÈnio diclofenac e o método de fabricação do mesmo.
ES2226102T3 (es) Administracion transdermica de farmacos basicos usando sistemas adhesivos no polares y agentes sdolubilizantes acidos.
BR0114909A (pt) Dispositivos de distribuição de drogas transdérmicas possuindo microprotuberâncias revestidas
CL2003002767A1 (es) Composicion oral que comprende una pelicula que contiene un material funcional, en un vehiculo, util para el cuidado oral.
CO5700698A2 (es) Composiciones y metodos para el cuidado oral y personal
DK0644746T3 (da) Anvendelse af glycerin til moderering af transdermal lægemiddelafgivelse
WO2004075933A3 (en) Devices for releasing volatile substances and methods of producing the devices
DK302782A (da) Anvendelse af eucalypol til at foroege et praeparats optagelse gennem huden
UY24117A1 (es) Tratamiento antifungal de las uñas.
NO20034684D0 (no) Innretning for administrering av midler gjennom stratum corcum
WO2004030743A3 (en) Drug delivery device having coated microprojections incorporating vasoconstrictors
BR0308137A (pt) Formulações de droga de liberação constante contendo um peptìdeo veìculo
NO993385L (no) Transdermalt terapeutisk system for avgivelse av hormoner
CO6361907A2 (es) Suministro transdermico de farmaco empleando un osmolito y un agente vasoactivo
AR032872A1 (es) Composicion para aclarar la piel y el metodo de aplicacion
AR019715A1 (es) Sistema terapeutico percutaneo, que contiene hormonas e inhibidores de cristalizacion
CO4810377A1 (es) Dispositivo para el suministro de plaguicidas agricolas
AR064262A1 (es) Composiciones farmaceuticas liquidas que comprenden un compuesto bisfosfonato
SV2006001970A (es) Hormonas de administracion transdermica que no necesitan potenciadores de penetracion ref. p-sv-77.461/cd
PE20050443A1 (es) Formulaciones farmaceuticas transdermicas
IE810489L (en) Composition for topical application
BR9916814A (pt) Composição cosmética pulverizável e matriz utilizável nessa composição para uma administração dérmica
SE9601527D0 (sv) Transdermally alministered acetylcysteine as mucolytic agent

Legal Events

Date Code Title Description
FG Grant, registration